skip to main content
European Commission logo
en English

News article

Open Market Consultation: Next Generation Sequencing for personalised cancer therapy

Seven hospitals from Austria, Italy, Germany, the Netherlands and France are inviting potentially interested bidders to participate in the open market consultation for their upcoming pre-commercial procurement on Next Generation Sequencing (NGS). The aim is to develop and test two fully integrated, standardized NGS workflows, from sample-pre-analytics to medical decision making, for routine diagnostics of common and rare cancers from adults and children. The open market consultation is planned to take place 22-23 March 2021 in Vienna. Registration deadline: 1 March 2020.

Logo of the project for Instand Next Generation Sequencing for Personalised cancer therapy
Logo shows the letters NGS and a genome sequence woven through the letters

permalinkMain URL

See alsoProject website